Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93760741 | 9376074 | 1 | I | 20130301 | 20130619 | 20130630 | 20130630 | EXP | GB-TEVA-413783ISR | TEVA | 65.00 | YR | F | Y | 91.00000 | KG | 20130630 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93760741 | 9376074 | 1 | PS | SIMVASTATIN | 1 | U | 76052 | ||||||||||||
| 93760741 | 9376074 | 2 | C | BENDROFLUMETHIAZIDE | 1 | D | 0 | ||||||||||||
| 93760741 | 9376074 | 3 | C | CLOPIDOGREL | 1 | D | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93760741 | 9376074 | OT |
| 93760741 | 9376074 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93760741 | 9376074 | Lethargy | |
| 93760741 | 9376074 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93760741 | 9376074 | 1 | 20130213 | 20130313 | 0 | |
| 93760741 | 9376074 | 2 | 20130213 | 20130313 | 0 | |
| 93760741 | 9376074 | 3 | 20130227 | 20130327 | 0 |